It’s been a soft start to the week for London’s AIM Index, with Wall Street closed and the overall trend being one of downside pressure amidst concern over the outlook for China’s economy. By the close the AIM All Share was just over two points lower at 790.11.
- Strip Tinning +20%
- Creo Medical +18%
- Panthera Resources +27%
- Allergy Therapeutics -78%
- Univision Engineering -44%
Strip Tinning LON:STG toped the board, adding 20% although there’s nothing much to see here for the company which only came to market less than 18 months ago. Transactions have been very limited and the move is within the spread quoted at the close.
Creo Medical LON:CREO was in second place, adding 18% on the day. The company announced it had received a regulatory clearance this morning for the use of its new therapy in Europe. This takes gains from the last month to almost 60%.
Panthera Resources LON:PAT gets the notable mention, up 17% on the day. There’s no news but as we noted last week, there’s a significant update expected from the company’s Bhukia project in the near term. Traders were limited and volumes far from exceptional.
Allergy Therapeutics LON:AGY was the biggest faller, off 78% after the company’s share listing was restored. Publication of the full year accounts to 30th June had been delayed pending a requirement for further funding and completion of the audit. Today also saw interims released and they made for tough reading with headline metrics moving in the wrong direction.
- Small Cap Stocks: Creo Medical, Nostra Terra, Proton Motor Power
- Small Cap Stocks: GRC, Strip Tinning, Clontarf Energy
Univision Engineering LON:UVEL was down 44%, again as trading in the stock was restored. The company is embroiled in a number of contractual disputes and today’s note advises of material uncertainty over its ability to remain a going concern. A number of financing options are said to be under consideration.
